Brief: Mersana Therapeutics Provides Business Update And Announces Q1 2023 Financial Results
09/05/2023 12:59
May 9 (Reuters) - Mersana Therapeutics Inc MRSN.O :
* MERSANA THERAPEUTICS PROVIDES BUSINESS UPDATE AND
ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS
* EXPECTS THAT ITS AVAILABLE FUNDS WILL BE SUFFICIENT TO
SUPPORT
ITS OPERATING PLAN COMMITMENTS INTO SECOND HALF OF 2024
* NET LOSS FOR Q1 OF 2023 WAS $56.2 MILLION, OR $0.52 PER
SHARE
* Q1 EARNINGS PER SHARE VIEW $-0.44, REVENUE VIEW $18.3
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNX4yptks
Further company coverage: MRSN.O
((Reuters.Briefs@thomsonreuters.com;))